Comment on: “A Systematic Review of the Cost-Effectiveness of Biologics for Ulcerative Colitis”
Crossref DOI link: https://doi.org/10.1007/s40273-018-0655-0
Published Online: 2018-05-04
Published Print: 2018-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Singh, Ena
Funding for this research was provided by:
Pfizer Inc.
Text and Data Mining valid from 2018-05-04
Article History
First Online: 4 May 2018